Changes in gap junctional connexin isoforms during prostate cancer progression

Prostate

Volumn 66, Issue 1, 2006, Pages 19-31

  Tate, Amanda W ^a   Lung, Tina ^a   Radhakrishnan, Anu ^a   Lim, So Dug ^a   Lin, Xi ^b   Edlund, Magnus ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Adhesion; Cell motility; Connexin; Cx26; FAK; Integrin

Indexed keywords

CALCIUM ION; CONNEXIN 26; CONNEXIN 32; CONNEXIN 43; CONNEXIN 45; FOCAL ADHESION KINASE; GAP JUNCTION PROTEIN; INTEGRIN; ISOPROTEIN; RNA;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL STRAIN PC 3; CONTROLLED STUDY; GAP JUNCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CONNEXINS; DISEASE PROGRESSION; GAP JUNCTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; ORGAN CULTURE TECHNIQUES; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 29344472071     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20317     Document Type: Article

References (84)

1. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996;93(5):1831-1835.
2. Carystinos GD, Katabi MM, Laird DW, Galipeau J, Chan H, Alaoui-Jamali MA, Batist G. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy. Clin Cancer Res 1999;5(1):61-68.
3. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA 2001;98(2):473-478.
4. Matono S, Tanaka T, Sueyoshi S, Yamana H, Fujita H, Shirouzu K. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer. Int J Oncol 2003;23(5):1309-1315.
5. Goodenough DA, Paul DL. Beyond the gap: Functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003;4(4):285-294.
6. Alexander DB, Goldberg GS. Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem 2003;10(19):2045- 2058.
7. Goldberg GS, Moreno AP, Lampe PD. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem 2002;277(39):36725-36730.
8. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 1998;3:D208-D236.
9. Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD, Hodgins MB. Up-regulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 1999;112(3):354-361.
10. Krutovskikh VA, Piccoli C, Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 2002;21(13):1989-1999.
11. Evans WH, Martin PE. Gap junctions: Structure and function (review). Mol Membr Biol 2002;19(2):121-136.
12. Bruzzone R, White TW, Paul DL. Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 1996;238(1):1-27.
13. Czyz J, Irmer U, Schulz G, Mindermann A, Hulser DF. Gap-junctional coupling measured by flow cytometry. Experimental Cell Research 2000;255(1):40-46.
14. Tomasetto C, Neveu MJ, Daley J, Horan PK, Sager R. Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J Cell Biol 1993;122(1):157-167.
15. Pearson RA, Dale N, Llaudet E, Mobbs P. ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 2005;46(5):731-744.
16. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 2002;277(10):8648-8657.
17. Carystinos GD, Kandouz M, Alaoui-Jamali MA, Batist G. Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence. Mol Pharmacol 2003;63(4):821-831.
18. Giepmans BN, Hengeveld T, Postma FR, Moolenaar WH. Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. J Biol Chem 2001;276(11):8544-8549.
19. Kojima T, Kokai Y, Chiba H, Yamamoto M, Mochizuki Y, Sawada N. Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp Cell Res 2001;263(2):193-201.
20. Kausalya PJ, Reichert M, Hunziker W. Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett 2001;505(1):92-96.
21. Xu X, Li WE, Huang GY, Meyer R, Chen T, Luo Y, Thomas MP, Radice GL, Lo CW. Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J Cell Biol 2001;154(1):217-230.
22. Wu JC, Tsai RY, Chung TH. Role of catenins in the development of gap junctions in rat cardiomyocytes. J Cell Biochem 2003;88(4):823-835.
23. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984;44(8):3522-3529.
24. Wu HC, Hsieh JT, Cleave ME, Brown NM, Pathak S, Chung LW. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells. Int J Cancer 1994;57(3):406-412.
25. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. [erratum appears in Cancer Res 1994 Jul 15;54(14):3953]. Cancer Res 1994;54(10):2577-2581.
26. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17(1):16-23.
27. Festuccia C, Gravina GL, Angelucci A, Millimaggi D, Bologna M. Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line. Anticancer Research 2000;20(6B):4367-4371.
28. Pozzi A, Risek B, Kiang DT, Gilula NB, Kumar NM. Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 1995;220(1):212-219.
29. John H, Wang X, Wehrli E, Hauri D, Maake C. Evidence of gap junctions in the stable nonobstructed human bladder. J Urol 2003;169(2):745-749.
30. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 1991;115(5):1357-1374.
31. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994;173(4):371-379.
32. Goodwin AE, Pauli BU. A new adhesion assay using buoyancy to remove non-adherent cells. J Immunol Methods 1995;187(2):213-219.
33. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 1999;24(1-2):91-110.
34. Hossain MZ, Jagdale AB, Ao P, LeCiel C, Huang RP, Boynton AL. Impaired expression and posttranslational processing of connexin43 and down-regulation of gap junctional communication in neoplastic human prostate cells. Prostate 1999;38(1):55-59.
35. Mesnil M. Connexins and cancer. Biol Cell 2002;94(7-8):493-500.
36. King TJ, Lampe PD. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. Carcinogenesis 2004;25(5):669-680.
37. Habermann H, Ray V, Habermann W, Prins GS. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 2001;166(6):2267-2272.
38. Kanczuga-Koda L, Sulkowska M, Koda M, Reszec J, Famulski W, Baltaziak M, Sulkowski S. Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland. Folia Morphol (Warsz) 2003;62(4):439-442.
39. Jamieson S, Going JJ, D'Arcy R, George WD. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol 1998;184(1):37-43.
40. Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, Donahue HJ. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001;61(5):1765-1767.
41. Wilgenbus K, Kirkpatrick C, Knuechel R, Willecke K, Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 1992;51:522-529.
42. Zhang W, Couldwell WT, Simard MF, Song H, Lin JH, Nedergaard M. Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 1999;59(8):1994-2003.
43. Donahue HJ, Saunders MM, Li Z, Mastro AM, Gay CV, Welch DR. A potential role for gap junctions in breast cancer metastasis to bone. J Musculoskel Neuron Interact 2003;3(2):156-161.
44. Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG. Transforming growth factor-betal activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 2003;22(28):4314-4332.
45. Asamoto M, Takahashi S, Imaida K, Shirai T, Fukushima S. Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis. Carcinogenesis 1994;15(10):2163-2166.
46. Trosko JE. The role of stem cells and gap junctional intercellular communication in carcinogenesis. J Biochem Mol Biol 2003;36(1):43-48.
47. Tanaka M, Grossman HB. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep 2004;11(2):537-541.
48. Roux AF, Pallares-Ruiz N, Vielle A, Faugere V, Templin C, Leprevost D, Artieres F, Lina G, Molinari N, Blanchet P, Mondain M, Claustres M. Molecular epidemiology of DFNB1 deafness in France. BMC Med Genet 2004;5(1):5.
49. Simsek M, Al-Wardy N, Al-Khayat A, Shanmugakonar M, Al-Bulushi T, Al-Khabory M, Al-Mujeni S, Al-Harthi S. Absence of deafness-associated connexin-26 (GJB2) gene mutations in the Omani population. Hum Mutat 2001;18(6):545-546.
50. Mese G, Londin E, Mui R, Brink PR, White TW. Altered gating properties of functional Cx26 mutants associated with recessive non-syndromic hearing loss. Hum Genet 2004;115(3):191-199.
51. D'Andrea P, Veronesi V, Bicego M, Melchionda S, Zelante L, Di Iorio E, Bruzzone R, Gasparini P. Hearing loss: Frequency and functional studies of the most common connexin26 alleles. Biochem Biophys Res Commun 2002;296(3):685-691.
52. Rabionet R, Lopez-Bigas N, Arbones ML, Estivill X. Connexin mutations in hearing loss, dermatological and neurological disorders. Trends Mol Med 2002;8(5):205-212.
53. Avraham KB. Inherited connexin mutations associated with hearing loss. Cell Commun Adhes 2001;8(4-6):419-424.
54. Ahmad S, Chen S, Sun J, Lin X. Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun 2003;307(2):362-368.
55. Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF, Willecke K. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995;129(3):805-817.
56. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004;36(7):1171-1186.
57. Traub O, Look J, Dermietzel R, Brummer F, Hulser D, Willecke K. Comparative characterization of the 21- and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J Cell Biol 1989;108(3):1039-1051.
58. Evans WH, Boitano S. Connexin mimetic peptides: Specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 2001;29(Pt 4):606-612.
59. Guan X, Wilson S, Schlender KK, Ruch RJ. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid. Mol Carcinog 1996;16(3):157-164.
60. George CH, Martin PE, Evans WH. Rapid determination of gap junction formation using HeLa cells microinjected with cDNAs encoding wild-type and chimeric connexins. Biochem Biophys Res Commun 1998;247(3):785-789.
61. Cruciani V, Mikalsen SO. Ilimaquinone inhibits gap junctional communication in a connexin isotype-specific manner. Exp Cell Res 2005;304(1):136-148.
62. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004;14(1):92-101.
63. Gabarra-Niecko V, Schaller MD, Dunty JM. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 2003;22(4):359-374.
64. Hecker TP, Gladson CL. Focal adhesion kinase in cancer. Front Biosci 2003;8:s705-s714.
65. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD. Differential regulation of cell motility and invasion by FAK. J Cell Biol 2003;160(5):753-767.
66. Lampe PD, Nguyen BP, Gil S, Usui M, Olerud J, Takada Y, Carter WG. Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol 1998;143(6):1735-1747.
67. Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 1997;9(1):86-92.
68. Kjoller L, Hall A. Signaling to Rho GTPases. Exp Cell Res 1999;253(1):166-179.
69. Alford AI, Rannels DE. Extracellular matrix fibronectin alters connexin43 expression by alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2001;280(4):L680-L688.
70. Guo Y, Martinez-Williams C, Yellowley CE, Donahue HJ, Rannels DE. Connexin expression by alveolar epithelial cells is regulated by extracellular matrix. Am J Physiol Lung Cell Mol Physiol 2001;280(2):L191-202.
71. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 2003;83(4):1359-1400.
72. Kwak BR, Hermans MM, De Jonge HR, Lohmann SM, Jongsma HJ, Chanson M. Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions. Mol Biol Cell 1995;6(12):1707-1719.
73. Li GY, Lin HH, Tu ZJ, Kiang DT. Gap junction Cx26 gene modulation by phorbol esters in benign and malignant human mammary cells. Gene 1998;209(1-2):139-147.
74. Butkevich E, Hulsmann S, Wenzel D, Shirao T, Duden R, Majoul I. Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton. Curr Biol 2004;14(8):650-658.
75. Gluck U, Ben-Ze'ev A. Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. J Cell Sci 1994;107(Pt 7):1773-1782.
76. Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 2002;4(3):191-194.
77. Davis TL, Cress AE, Dalkin BL, Nagle RB. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001;46(3):240-248.
78. Fornaro M, Manes T, Languino LR. Integrins and prostate cancer metastases. Cancer Metastasis Rev 2001;20(3-4):321-331.
79. Juliano RL, Varner JA. Adhesion molecules in cancer: The role of integrins. Curr Opin Cell Biol 1993;5(5):812-818.
80. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, Otey CA, Zhau HE, Chung LW. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 2001;12(2):99-107.
81. Nagy JI, Hossain MZ, Lynn BD, Curpen GE, Yang S, Turley EA. Increased connexin-43 and gap junctional communication correlate with altered phenotypic characteristics of cells overexpressing the receptor for hyaluronic acid-mediated motility. Cell Growth Differ 1996;7(6):745-751.
82. Chung LW, Hsieh CL, Law A, Sung SY, Gardner TA, Egawa M, Matsubara S, Zhau HE. New targets for therapy in prostate cancer: Modulation of stromal-epithelial interactions. Urology 2003;62(5 Suppl 1):44-54.
83. Edlund M, Sung SY, Chung LW. Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem 2004;91(4):686-705.
84. Sung SY, Chung LW. Prostate tumor-stroma interaction: Molecular mechanisms and opportunities for therapeutic targeting. Differentiation 2002;70(9-10):506-521.